be_ixf;ym_202411 d_23; ct_50
NYSE:SPR charts & data provided by TradingView

Latest Insights on SPR

The strong dollar can help you turbocharge a revenue-producing asset play. It's a play you should consider making … before it’s too late. Time Is Running Out to Turbocharge Your Investments
by Ted Bauman November 20, 2017 Currency, Global Economy
There's a way to turbocharge a revenue-producing asset play. It's a play you should consider making … before it’s too late.
Why Fidelity National is Setting Up for its Next Leg Higher
by Optin November 15, 2017 Pivotal Point Trader
The financial services sector is in the midst of a digital transformation. With 20,000 clients worldwide and 27 billion transactions processed, Fidelity National Information Services (FIS) is in a unique position to capitalize. Its business and share price have reached a pivotal point of inflection, which is why we put them in our Pivotal Point Trader portfolio last week. […]
Trade Alert: Time to Book Another 50% Plus Gain
by Optin November 9, 2017 Adventure Capitalist
We’ve booked our fair share of 50%-plus winners in 2017: Glu Mobile (GLUU) +81%, Camtek (CAMT) +50% and Encana (ECA) +83%. (Myers Industries (MYE) didn’t make the 50% and above cut, but it still landed us a +40% gain.) Today, let’s add another one to our list … I recommended AeroVironment (AVAV) in this year’s April issue. AeroVironment makes small unmanned aircraft systems, advanced development […]
Allocating part of your portfolio to this proven, time-based strategy is essential. You're practically guaranteed to beat the market. What’s The Stock Market? S&P500 & More Explained
by Ted Bauman November 6, 2017 Trading Strategies
Allocating part of your portfolio to this proven, time-based strategy is essential. You're practically guaranteed to beat the market.
If tests on animals continue to be successful, gene editing could be the long-awaited cure for cancer, AIDS and many other diseases. Gene Editing: The Cure for Every Disease?
by Ian Dyer November 2, 2017 Investment Opportunities
If tests on animals continue to be successful, gene editing could be the long-awaited cure for cancer, AIDS and many other diseases.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

"You told me to ignore the noise on Wall Street. And thanks to you, I started towards the end of 2016 with $200,000 in my account and I recently put in an extra $100,000. [As of February 2019] My account is worth $500,788! I would’ve missed out if I followed conventional wisdom."

- Helen C.

“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”

- David G. (Member since 2018)

Share This